Nano-X Imaging is an Israeli medical-imaging company whose public story has always been the Nanox.ARC, a compact digital tomosynthesis scanner built around a cold-cathode X-ray source. The second-quarter print instead shows a services company that bought a health-information-technology tuck-in and is still waiting for hardware to become a business. Revenue rose, but almost all of the increase traces to the November consolidation of Nanox Health IT, formerly Vaso Healthcare IT, rather than to scanners leaving the loading dock. That acquired unit contributed $0.9 million in the quarter. The investment debate is whether a book of distribution agreements and a first Imaging Network site can convert into recognized system sales before cash and the going-concern clock force another round of cheap equity.
The hardware line remains a rounding error next to teleradiology and software. Imaging systems and original-equipment work contributed $0.2 million. Teleradiology contributed $3.0 million. That mix is the opposite of what the original listing narrative promised. Management has already withdrawn the full-year revenue target set in April, citing longer gaps between signed agreements, site construction, and revenue recognition. About forty ARC units sit in various stages of deployment, and the company said there was no material change in that count during the quarter. A distribution book that talks about hundreds of capital-equipment placements is not the same thing as scanners that scan and get paid.
Cash fell from a year-end $60 million to $31.4 million by mid-year. After the quarter the company raised $8.5 million through a registered-direct sale and the at-the-market program, a shelf facility that lets an issuer sell shares into the open market over time. GAAP results were dominated by a $40.7 million write-down of artificial-intelligence intangible assets. The question for the next several quarters is whether Nanox.ARC placements start producing paid scans fast enough to change the cash math, or whether the equity remains a repeatedly refinanced option on a scanner that hospitals are slow to adopt.